Skip to content

Teleflex TFX Cash & Equivalents

Cash & Equivalents at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$1.02B+49.0%
Boston Scientific logo
Boston ScientificBSX
$850M+146%
Medtronic logo
MedtronicMDT
$1.95B-12.1%
Stryker logo
StrykerSYK
$2.88B+24.1%
Solventum logo
SolventumSOLV
$561M+5.1%
Baxter International logo
Baxter InternationalBAX
$2.02B-12.1%

Other financials

Income statement

See full
Revenue$548.3M+32.3%
Gross profit$307.4M+20.4%
Operating income$20.2M-73.4%
Net income-$8.2M-109%
EPS (diluted)-$0.18-109%

Balance sheet

See full
Total debt$2.8B+38.6%
Total equity$3.1B-24.7%
Total assets$6.8B-5.3%

Cash flow

See full
Operating cash flow$46.7M+68.3%
CapEx$18.8M-22.1%
Free cash flow$27.9M+676%

Valuation

See full
Market cap$5.62B-14.4%
Enterprise value$8.07B-2.0%
P/S2.6×-1.2×

Profitability

See full
Gross margin38.2%-3.0pp
Operating margin3%-11.8pp
Net margin-47.4%-56.2pp
FCF margin7.9%

Returns & leverage

See full
Return on equity-28.1%-31.6pp
Debt / equity0.9×+0.4×
Current ratio2.6×+0.3×

Where this comes from

Reported directly by Teleflex in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Teleflex’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Teleflex's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Teleflex's cash & equivalents?
Teleflex (TFX) reported cash & equivalents of $329.55M in Q1 2026.
How has Teleflex's cash & equivalents changed year-over-year?
Teleflex's cash & equivalents increased by 16.8% year-over-year, from $282.08M to $329.55M.
What is the long-term trend for Teleflex's cash & equivalents?
Over 5 years (2020 to 2025), Teleflex's cash & equivalents has grown at a 1.4% compound annual growth rate (CAGR), from $375.88M to $402.68M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.